|
|
 |
ASCORBIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$798.00 |
|
|
 |
AMMONIO METHACRYLATE COPOLYMER TYPE B Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADVAIR HFA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AKLIEF Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALVESCO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|